Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.
Saved in:
| Title: | Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. |
|---|---|
| Authors: | Durier C; INSERM US19, Villejuif, France. Electronic address: christine.durier@inserm.fr., Ninove L; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., van der Werf S; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France., Lefebvre M; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France., Desaint C; INSERM US19, Villejuif, France; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Bauer R; INSERM US19, Villejuif, France., Attia M; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France., Lecompte AS; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France., Lachatre M; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Maakaroun-Vermesse Z; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France; CHU Lyon-Sud, Pierre-Bénite, France., Verdon R; Service de Maladies Infectieuses, CHU de Caen, Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France., Kiladjian JJ; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France., Loubet P; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Montpellier, France., Schmidt-Mutter C; INSERM CIC 1434, CHU Strasbourg, Strasbourg, France., Corbin V; CHU Clermont-Ferrand, INSERM CIC1405, Clermont-Ferrand, France., Ansart S; INSERM CIC 1412, CHU Brest, Brest, France., Melica G; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, INSERM CIC 1430, Créteil, France., Resch M; INSERM US19, Villejuif, France., Netzer E; INSERM US19, Villejuif, France., Kherabi Y; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Tardieu R; ANRS Emerging Infectious Diseases, Paris, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, Créteil, France., Tartour E; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France., Meyer L; INSERM US19, Villejuif, France; INSERM, CESP U1018, Université Paris Saclay, APHP, Le Kremlin-Bicêtre, France., de Lamballerie X; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Launay O; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France. |
| Corporate Authors: | ANRS002S CoviCompareP group |
| Source: | Infectious diseases now [Infect Dis Now] 2024 Aug; Vol. 54 (5), pp. 104886. Date of Electronic Publication: 2024 Mar 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Masson Country of Publication: France NLM ID: 101775152 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-9919 (Electronic) Linking ISSN: 26669919 NLM ISO Abbreviation: Infect Dis Now Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38494117 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Durier+C%22">Durier C</searchLink>; INSERM US19, Villejuif, France. Electronic address: christine.durier@inserm.fr.<br /><searchLink fieldCode="AU" term="%22Ninove+L%22">Ninove L</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22van+der+Werf+S%22">van der Werf S</searchLink>; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lefebvre+M%22">Lefebvre M</searchLink>; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Desaint+C%22">Desaint C</searchLink>; INSERM US19, Villejuif, France; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bauer+R%22">Bauer R</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Attia+M%22">Attia M</searchLink>; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lecompte+AS%22">Lecompte AS</searchLink>; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Lachatre+M%22">Lachatre M</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Maakaroun-Vermesse+Z%22">Maakaroun-Vermesse Z</searchLink>; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+JF%22">Nicolas JF</searchLink>; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France; CHU Lyon-Sud, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Verdon+R%22">Verdon R</searchLink>; Service de Maladies Infectieuses, CHU de Caen, Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Loubet+P%22">Loubet P</searchLink>; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; INSERM CIC 1434, CHU Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Corbin+V%22">Corbin V</searchLink>; CHU Clermont-Ferrand, INSERM CIC1405, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Ansart+S%22">Ansart S</searchLink>; INSERM CIC 1412, CHU Brest, Brest, France.<br /><searchLink fieldCode="AU" term="%22Melica+G%22">Melica G</searchLink>; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, INSERM CIC 1430, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Resch+M%22">Resch M</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Netzer+E%22">Netzer E</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Kherabi+Y%22">Kherabi Y</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tardieu+R%22">Tardieu R</searchLink>; ANRS Emerging Infectious Diseases, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lelièvre+JD%22">Lelièvre JD</searchLink>; INSERM U955, Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Tartour+E%22">Tartour E</searchLink>; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Meyer+L%22">Meyer L</searchLink>; INSERM US19, Villejuif, France; INSERM, CESP U1018, Université Paris Saclay, APHP, Le Kremlin-Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Launay+O%22">Launay O</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ANRS002S+CoviCompareP+group%22">ANRS002S CoviCompareP group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101775152%22">Infectious diseases now</searchLink> [Infect Dis Now] 2024 Aug; Vol. 54 (5), pp. 104886. <i>Date of Electronic Publication: </i>2024 Mar 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Masson%22">Elsevier Masson </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101775152 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-9919 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226669919%22">26669919 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Now <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38494117 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.idnow.2024.104886 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104886 Titles: – TitleFull: Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Durier C – PersonEntity: Name: NameFull: Ninove L – PersonEntity: Name: NameFull: van der Werf S – PersonEntity: Name: NameFull: Lefebvre M – PersonEntity: Name: NameFull: Desaint C – PersonEntity: Name: NameFull: Bauer R – PersonEntity: Name: NameFull: Attia M – PersonEntity: Name: NameFull: Lecompte AS – PersonEntity: Name: NameFull: Lachatre M – PersonEntity: Name: NameFull: Maakaroun-Vermesse Z – PersonEntity: Name: NameFull: Nicolas JF – PersonEntity: Name: NameFull: Verdon R – PersonEntity: Name: NameFull: Kiladjian JJ – PersonEntity: Name: NameFull: Loubet P – PersonEntity: Name: NameFull: Schmidt-Mutter C – PersonEntity: Name: NameFull: Corbin V – PersonEntity: Name: NameFull: Ansart S – PersonEntity: Name: NameFull: Melica G – PersonEntity: Name: NameFull: Resch M – PersonEntity: Name: NameFull: Netzer E – PersonEntity: Name: NameFull: Kherabi Y – PersonEntity: Name: NameFull: Tardieu R – PersonEntity: Name: NameFull: Lelièvre JD – PersonEntity: Name: NameFull: Tartour E – PersonEntity: Name: NameFull: Meyer L – PersonEntity: Name: NameFull: de Lamballerie X – PersonEntity: Name: NameFull: Launay O IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2666-9919 Numbering: – Type: volume Value: 54 – Type: issue Value: 5 Titles: – TitleFull: Infectious diseases now Type: main |
| ResultId | 1 |